Research paperMethionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin (cas 19683-98-8)
-
Add time:09/01/2019 Source:sciencedirect.com
Background: Angiogenesis, the formation of new blood vessels, is essential for tumor growth. The inhibition of angiogenesis is therefore emerging as a promising therapy for cancer. Two natural products, fumagillin and ovalicin, were discovered to be potent inhibitors of angiogenesis due to their inhibition of endothelial cell proliferation. An analog of fumagillin, AGM-1470, is currently undergoing clinical trials for the treatment of a variety of cancers. The underlying molecular mechanism of the inhibition of angiogenesis by these natural drugs has remained unknown.Results: Both AGM-1470 and ovalicin bind to a common bifunctional protein, identified by mass spectrometry as the type 2 methionine aminopeptidase (MetAP2). This protein also acts as an inhibitor of eukaryotic initiation factor 2α (elF-2α) phosphorylation. Both drugs potently inhibit the methionine aminopeptidase activity of MetAP2 without affecting its ability to block eIF-2α phosphorylation. There are two types of methionine aminopeptidase found in eukaryotes, but only the type 2 enzyme is inhibited by the drugs. A series of analogs of fumagillin and ovalicin were synthesized and their potency for inhibition of endothelial cell proliferation and inhibition of methionine aminopeptidase activity was determined. A significant correlation was found between the two activities.Conclusions: The protein MetAP2 is a common molecular target for both AGM-1470 and ovalicin. This finding suggests that MetAP2 may play a critical role in the proliferation of endothelial cells and may serve as a promising target for the development of new anti-angiogenic drugs.
We also recommend Trading Suppliers and Manufacturers of ovalicin (cas 19683-98-8). Pls Click Website Link as below: cas 19683-98-8 suppliers
Prev:Total syntheses of (±)-ovalicin (cas 19683-98-8), C4(S∗)-isomer, and its C5-analogs and anti-trypanosomal activities
Next:The allenic Alder-ene reaction: constitutional group selectivity and its application to the synthesis of ovalicin (cas 19683-98-8)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research PaperSelective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin (cas 19683-98-8) in endothelial cells09/09/2019
- Enantioselective formal synthesis of (−)-ovalicin (cas 19683-98-8) using quinic acid as a chiral template109/08/2019
- The biosynthesis of ovalicin (cas 19683-98-8) from β-trans-bergamotene09/07/2019
- QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin (cas 19683-98-8) analogues: another example of an allosteric interaction09/06/2019
- Synthetic analogues of TNP-470 and ovalicin (cas 19683-98-8) reveal a common molecular basis for inhibition of angiogenesis and immunosuppression109/05/2019
- Simple and efficient synthesis of highly functionalized cyclohexanes; formal total synthesis of ovalicin (cas 19683-98-8) and fumagillin09/04/2019
- A novel stereoselective route to a fumagillin and ovalicin (cas 19683-98-8) synthetic intermediate09/03/2019
- The allenic Alder-ene reaction: constitutional group selectivity and its application to the synthesis of ovalicin (cas 19683-98-8)09/02/2019
- Total syntheses of (±)-ovalicin (cas 19683-98-8), C4(S∗)-isomer, and its C5-analogs and anti-trypanosomal activities08/31/2019


